- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Influx Healthtech IPO
₹1,09,200/1200 shares
Minimum Investment
IPO Details
18 Jun 25
20 Jun 25
₹1,09,200
1200
₹91 to ₹96
NSE
₹58.57 Cr
25 Jun 25
Influx Healthtech IPO Timeline
Bidding Start
18 Jun 25
Bidding Ends
20 Jun 25
Allotment Finalisation
23 Jun 25
Refund Initiation
24 Jun 25
Demat Transfer
24 Jun 25
Listing
25 Jun 25
Influx Healthtech Limited
Influx Healthtech Limited, established in September 2020, is a healthcare-focused company known for its expertise in contract manufacturing. Serving as a dependable CDMO, it offers specialised services across various sectors. Operating three facilities in Thane, Maharashtra, the company covers areas of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its diverse product range includes tablets, capsules, softgels, jellies, ODFs, effervescent tablets, cosmetics, herbal formulations, veterinary and homecare products. Supporting nutraceutical and cosmetic firms, it provides end-to-end development, production, and regulatory services. As of June 11, 2025, it employs 163 permanent staff.
Influx Healthtech IPO Overview
The Influx Healthtech IPO is a book-built issue worth ₹58.57 crores, comprising a fresh issue of 50 lakh equity shares totalling ₹48.00 crores and an offer for sale of 11 lakh shares amounting to ₹10.56 crores. The IPO will open for subscription on June 18, 2025, and close on June 20, 2025. Allotment is likely to be finalised on June 23, with a tentative listing on NSE SME scheduled for June 25, 2025. The price band is set between ₹91 and ₹96 per share.
The minimum application size for retail investors is 1,200 shares, requiring an investment of ₹1,09,200, though bidding at the cut-off price of ₹1,15,200 is recommended to avoid the risk of missing allotment in case of oversubscription. For HNIs, the minimum investment is two lots (2,400 shares) amounting to ₹2,30,400. Rarever Financial Advisors Pvt. Ltd. is the book-running lead manager, with Maashitla Securities Private Limited acting as registrar. R.K. Stock Holding Private Limited will serve as the market maker.
Influx Healthtech IPO Details
| Particulars | Details |
| IPO Date | 18 June 2025 to 20 June 2025 |
| Listing Date | 25 June 2025 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹91 to ₹96 per share |
| Lot Size | 1200 Shares |
| Total Issue Size | 61,00,800 shares (aggregating up to ₹58.57 Cr) |
| Fresh Issue | 50,00,400 shares (aggregating up to ₹48.00 Cr) |
| Offer for Sale | 11,00,400 shares of ₹10 (aggregating up to ₹10.56 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,81,50,000 shares |
| Share Holding Post Issue | 2,31,50,400 shares |
| Market Maker Portion | 3,06,000 shares |
Influx Healthtech IPO Reservation
| Investor Category | Shares Offered |
| QIB | Not more than 50% of the Net Issue |
| Retail | Not less than 35% of the Net Issue |
| NII (HNI) | Not less than 15% of the Net Issue |
Influx Healthtech IPO Lot Size
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 1200 | ₹1,15,200 |
| Retail (Max) | 1 | 1200 | ₹1,15,200 |
| HNI (Min) | 2 | 2400 | ₹2,30,400 |
Influx Healthtech IPO Promoter Holding
| Shareholding Status | Percentage |
| Pre-Issue | 99.85% |
| Post-Issue | 73.53% |
Influx Healthtech IPO Valuation Overview
| KPI | Value |
| Earnings Per Share (EPS) | 7.36 |
| Price/Earnings (P/E) Ratio | TBD |
| Return on Net Worth (RoNW) | 36.98% |
| Net Asset Value (NAV) | 19.91 |
| Return on Equity | 36.98% |
| Return on Capital Employed (ROCE) | 49.17% |
| EBITDA Margin | 19.62% |
| PAT Margin | 12.75% |
| Debt to Equity Ratio | 0.01 |
Objectives of the Proceeds
- Funding capital expenditure requirements for setting up of manufacturing facility for
- Nutraceutical Division ₹2,249.11 lakhs
- Funding capital expenditure requirements for setting up of manufacturing facility for
- Veterinary Food Division ₹1,148.58 lakhs
- Purchase of Machineries for Homecare and Cosmetic Division ₹275.65 lakhs
- Meet general corporate expenses
Key Financials (in ₹ lakhs)
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 7029.91 | 4110.31 | 2830.42 |
| Revenue | 10,485.36 | 9996.51 | 7605.55 |
| Profit After Tax | 1336.60 | 1112.80 | 719.63 |
| Reserves and Surplus | 1799.54 | 2275.44 | 1162.65 |
| Total Borrowings | 21.92 | 32.48 | 79.85 |
SWOT Analysis of Influx Healthtech IPO
Strength and Opportunities
- Strong CDMO capabilities across nutraceuticals, cosmetics, veterinary, homecare.
- Innovative liquid-fill & biodegradable pouch technologies.
- FSSAI Form II approval for magnesium glycinate expands product range.
- Growth potential via partnerships and patented formulations.
Risks and Threats
- Relatively new (founded 2020), limited market track record.
- Reliance on regulatory approvals may delay product launches.
- Intense competition from established CDMOs in India.
- Vulnerable to regulatory shifts, rawmaterial cost fluctuations.
Explore IPO Opportunities
Explore our comprehensive IPO pages to stay updated on the latest trends and insights.
About Influx Healthtech Limited
Influx Healthtech Limited IPO Strengths
- Offers a wide range of health, nutrition, and personal care products catering to multiple consumer and industry needs.
- Serves a varied base of clients across different sectors, enhancing business stability and market reach.
- Maintains high manufacturing standards with strict quality assurance and quality control systems across all product categories.
- Led by experienced promoters and a skilled management team with strong industry knowledge and strategic expertise.
Peer Group Comparison
| Name of the Company | Basic and Diluted EPS (₹) | Face Value (₹) | P/E Ratio (times)# | RoNW (%) | NAV per Share (₹) | Total Income (₹ in lakhs) |
| Influx Healthtech Limited | 7.36 | 10.00 | [●] | 36.98% | 19.91 | 10,498.67 |
| Peer Groups | ||||||
| Sudarshan Pharma Industries Limited | 0.66 | 1.00 | 48.28 | 12.45% | 5.30 | 50,538.39 |
| Quest Laboratories Limited | 8.28 | 10.00 | 10.38 | 16.58% | 49.92 | 10,815.87 |
How to apply IPO with HDFC SKY?
Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.
1Login to your HDFC SKY Account
2Select Issue
3Enter Number of Lots and your Price.
4Enter UPI ID
5Complete Transaction on Your UPI App
FAQs On Influx Healthtech IPO
How can I apply for Influx Healthtech IPO?
You can apply via HDFCSky, or other brokers using UPI-based ASBA (Application Supported by Blocked Amount).
What is the price band for the Influx Healthtech IPO?
The IPO price band is set between ₹91 to ₹96 per equity shar.
When will Influx Healthtech IPO shares be listed on NSE SME?
The shares are scheduled to be listed on NSE SME on 25 June 2025.
What is the minimum investment required for retail investors?
Retail investors must invest a minimum of ₹1,15,200 for one lot of 1,200 shares.
How many shares are being offered through the Influx Healthtech IPO?
A total of 61,00,800 shares are being offered, aggregating up to ₹58.57 crore.
By signing up I certify terms, conditions & privacy policy